• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • COVID-19

    Tanzania places 'massive' order for COVID-19 vaccines

    In a dramatic pivot for the government, Tanzania is now one of the African Union's largest buyers of Johnson & Johnson vaccines.

    By Sara Jerving // 22 July 2021
    An employee oversees the production of Sputnik V vaccines in St. Petersburg, Russia. Photo by: Sergey Ponomarev / IMF / CC BY-NC-ND

    Tanzania has placed a “massive” order with the African Union for COVID-19 vaccines, marking a turnaround for the country’s government, which previously made no effort to secure doses and whose recently deceased former president repeatedly belittled the science behind the coronavirus.

    Sign up for Devex CheckUp
    The must-read weekly newsletter for exclusive global health news and insider insights.

    The AU has secured 400 million doses of the Johnson & Johnson one-dose COVID-19 vaccine for purchase by African nations, which it will start shipping to countries next week. Tanzania is one of the biggest purchasers of those vaccines, said Strive Masiyiwa, special envoy to the AU, during a press conference Thursday — though he didn’t name the exact number of doses the country had ordered.

    “We have now seen a significant shift in Tanzania’s position,” said Dr. John Nkengasong, director of the Africa Centres for Disease Control and Prevention.

    Why it matters: Tanzania is one of three countries on the African continent that has not yet started a national COVID-19 vaccination campaign, according to Nkengasong, along with Eritrea, and Burundi.

    Under former President John Magufuli, the government spread misinformation and refused to release data on case count — which still officially stands at only 509 cases, last reported in May 2020. In early February, Health Minister Dorothy Gwajima announced the country had no plans to accept COVID-19 vaccines, despite the country’s eligibility to receive them for free.

    Since Magafuli’s death in March, President Samia Suluhu Hassan has changed Tanzania’s pandemic management, joining COVAX, in order to receive free doses. The country also expects to receive 360,000 doses of the J&J vaccine donated by the United States this month.

    While there has not yet been broad federal distribution, vaccines have found their way into the country through other means. For example, the semi-autonomous archipelago of Zanzibar secured 10,000 doses of Sputnik V, as well as Sinovac vaccines.

    • Global Health
    • Trade & Policy
    • Tanzania
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Sara Jerving

      Sara Jervingsarajerving

      Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.

    Search for articles

    Related Stories

    Global HealthAfrica’s vaccine manufacturing ambitions get a boost with new partnerships

    Africa’s vaccine manufacturing ambitions get a boost with new partnerships

    Most Read

    • 1
      The power of diagnostics to improve mental health
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      Opinion: Urgent action is needed to close the mobile gender gap
    • 4
      Supporting community-driven solutions to address breast cancer
    • 5
      No health reform without better AI governance
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement